Literature DB >> 20110838

The effect of two clinically relevant fusionless scoliosis implant strategies on the health of the intervertebral disc: analysis in an immature goat model.

Kenneth J Hunt1, John T Braun, Bryt A Christensen.   

Abstract

STUDY
DESIGN: Immature goat spines were instrumented at 5 levels with 2 different fusionless scoliosis implants. Instrumented and subadjacent spinal segments were analyzed to determine the effect on the disc and endplate.
OBJECTIVE: Analyze the regional biochemistry and histology of spinal motion segments in healthy goat spines treated with 2 clinically relevant, fusionless scoliosis implants. SUMMARY OF BACKGROUND DATA: Fusionless scoliosis surgery is thought to be more physiologic than fusion as it preserves the growth, motion, and function of the spine. There are presently little data supporting this belief.
METHODS: Scoliosis was created in twelve 8-week-old female goats (n = 6 per group) using 1 of 2 fusionless scoliosis implant strategies: 2 SMA staples per level or a bone anchor/ligament tether. A third group served as controls (n = 6). Goats were analyzed after 6 months. Qualitative and quantitative analyses were performed on spinal motion segments using H&E, TUNEL, and caspase-3 staining.
RESULTS: Neither implant strategy produced degenerative changes in the disc. However, discs at instrumented levels in both groups demonstrated decreased cell density (P < 0.01) and increased cellular apoptosis (P < 0.001) compared to controls. Subadjacent discs demonstrated preservation of viable cells and endplate vascularity compared to instrumented discs.
CONCLUSION: Fusionless scoliosis implants result in alterations in viable cell density within the disc and reduced vascularity in the vertebral endplates of instrumented but not subadjacent discs. Though obvious disc degeneration was not observed, the implications of the cellular and histologic changes are not known. Additional study will be necessary to better understand various fusionless scoliosis surgery strategies and their effect on surrounding tissues.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20110838     DOI: 10.1097/BRS.0b013e3181b962a4

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  7 in total

1.  Biomechanical comparison of fusionless growth modulation corrective techniques in pediatric scoliosis.

Authors:  Mark Driscoll; Carl-Eric Aubin; Alain Moreau; Stefan Parent
Journal:  Med Biol Eng Comput       Date:  2011-07-14       Impact factor: 2.602

Review 2.  [Adolescent scoliosis : From deformity to treatment].

Authors:  A Schulze; S Schrading; M Betsch; V Quack; M Tingart
Journal:  Orthopade       Date:  2015-11       Impact factor: 1.087

Review 3.  Spinal growth tethering: indications and limits.

Authors:  Peter O Newton
Journal:  Ann Transl Med       Date:  2020-01

4.  The modulation of spinal growth with nitinol intervertebral stapling in an established swine model.

Authors:  Joseph H Carreau; Christine L Farnsworth; Diana A Glaser; Joshua D Doan; Tracey Bastrom; Nathan Bryan; Peter O Newton
Journal:  J Child Orthop       Date:  2012-06-30       Impact factor: 1.548

5.  A novel fusionless vertebral physeal device inducing spinal growth modulation for the correction of spinal deformities.

Authors:  Eliane C Schmid; Carl-Eric Aubin; Alain Moreau; John Sarwark; Stefan Parent
Journal:  Eur Spine J       Date:  2008-08-19       Impact factor: 3.134

6.  Mechanobiological analysis of porcine spines instrumented with intra-vertebral staples.

Authors:  Alejandra Mejia Jaramillo; Carl-Éric Aubin; Bahe Hachem; Irene Londono; Juliette Pelletier; Stefan Parent; Isabelle Villemure
Journal:  J Musculoskelet Neuronal Interact       Date:  2019-03-01       Impact factor: 2.041

7.  The Establishment of a Mouse Model for Degenerative Kyphoscoliosis Based on Senescence-Accelerated Mouse Prone 8.

Authors:  Zongshan Hu; Ziyang Tang; Abdukahar Kiram; Jie Li; Hui Xu; Yanjie Xu; Huiming Jiang; Zezhang Zhu; Yong Qiu; Zhen Liu
Journal:  Oxid Med Cell Longev       Date:  2022-07-20       Impact factor: 7.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.